av/cyclo-therapeutics--big.svg

NASDAQ:CYTHW

Cyclo Therapeutics, Inc.

  • Stock

USD

Last Close

1.37

17/05 20:00

Market Cap

38.93M

Beta: -

Volume Today

21.59K

Avg: 2.95K

PE Ratio

−1.53

PFCF: −2.83

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.69M
-
1.57M
7.43%
950.46K
39.36%
1.50M
58.13%
1.24M
17.64%
1.01M
18.28%
1.01M
0.42%
903.38K
10.31%
1.59M
75.54%
1.38M
13.24%
1.08M
21.76%
cost of revenue
426.02K
-
272.64K
36.00%
124.42K
54.36%
198.43K
59.48%
132.92K
33.01%
105.03K
20.98%
75.49K
28.12%
66.40K
12.05%
156.08K
135.07%
138.93K
10.99%
3.49M
2,409.61%
gross profit
1.27M
-
1.29M
2.17%
826.03K
36.20%
1.30M
57.92%
1.10M
15.30%
906.45K
17.96%
931.71K
2.79%
836.98K
10.17%
1.43M
70.81%
1.24M
13.49%
-2.41M
294.87%
selling and marketing expenses
8.91K
-
10.90K
22.28%
7.57K
30.55%
7.16K
5.42%
7.85K
9.61%
5.64K
28.09%
5.88K
4.29%
5.01K
14.94%
18.34K
266.28%
13.06K
28.77%
3.90K
70.12%
general and administrative expenses
639.54K
-
1.53M
139.95%
2.22M
44.89%
2.64M
18.91%
2.62M
0.71%
2.43M
7.42%
3.43M
41.28%
3.68M
7.06%
6.50M
76.79%
7.81M
20.12%
5.66M
27.46%
selling general and administrative expenses
648.45K
-
1.55M
138.33%
2.23M
44.36%
2.65M
18.83%
2.63M
0.69%
2.44M
7.48%
3.44M
41.20%
3.68M
7.02%
6.52M
77.04%
7.82M
19.98%
3.46M
55.77%
research and development expenses
94.13K
-
658.50K
599.55%
1.86M
183.18%
2.29M
22.96%
2.71M
18.25%
4.87M
79.59%
6.10M
25.21%
9.15M
50.15%
9.00M
1.68%
14.18M
57.58%
other expenses
188.76K
-
217.52K
15.23%
202.01K
7.13%
130.95K
35.18%
19.77K
84.90%
13.95K
29.47%
13.98K
0.22%
19.95K
42.75%
27.54K
38.01%
30.50K
10.77%
cost and expenses
1.26M
-
2.13M
68.59%
3.22M
51.00%
4.85M
50.66%
5.08M
4.81%
5.27M
3.70%
8.40M
59.47%
9.86M
17.45%
15.85M
60.73%
16.99M
7.15%
21.13M
24.37%
operating expenses
837.21K
-
1.86M
121.82%
3.09M
66.47%
4.65M
50.31%
4.95M
6.43%
5.16M
4.36%
8.32M
61.25%
9.80M
17.72%
15.70M
60.23%
16.85M
7.33%
17.64M
4.70%
interest expense
53.87K
-
33.67K
37.49%
31.29K
7.08%
28.60K
8.59%
-150.45K
-
ebitda
578.14K
-
-409.87K
170.89%
-2.10M
411.49%
-3.24M
54.32%
-3.83M
18.43%
-4.24M
10.77%
-7.24M
70.67%
-8.97M
23.78%
-14.23M
58.74%
-15.75M
10.68%
-20.03M
27.16%
operating income
336.64K
-
-562.31K
267.03%
-2.41M
328.01%
-4.21M
74.75%
-3.84M
8.62%
-4.27M
11.02%
-7.39M
73.22%
-8.96M
21.23%
-14.27M
59.24%
-15.61M
9.42%
-20.05M
28.43%
depreciation and amortization
148.04K
-
152.45K
2.98%
169.03K
10.88%
107.10K
36.64%
9.27K
91.34%
10.12K
9.20%
147.43K
1,356.20%
-5.77K
103.91%
35.35K
712.95%
-141.25K
499.57%
19.28K
113.65%
total other income expenses net
-91.33K
-
3.30K
103.61%
-134.63K
4,179.70%
-853.02K
533.60%
7.58K
100.89%
-377
104.97%
-141.75K
37,498.14%
18.53K
113.07%
-18.52K
199.96%
160.73K
967.76%
-7.24K
104.51%
income before tax
284.91K
-
-592.69K
308.03%
-2.43M
310.23%
-4.22M
73.72%
-3.83M
9.25%
-4.26M
11.01%
-7.53M
77.03%
-8.94M
18.71%
-14.29M
59.78%
-15.45M
8.15%
-20.06M
29.81%
income tax expense
80K
-
33.67K
57.91%
120K
256.37%
28.60K
76.16%
11.77K
-
141.75K
1,103.98%
-18.53K
113.07%
18.52K
199.96%
-171.00K
1,023.22%
4
100.00%
net income
204.91K
-
-592.69K
389.24%
-2.55M
330.48%
-4.22M
65.55%
-3.83M
9.25%
-4.26M
11.01%
-7.67M
80.36%
-8.92M
16.27%
-14.31M
60.32%
-15.28M
6.81%
-20.06M
31.27%
weighted average shs out
371.66K
-
505.43K
35.99%
562.09K
11.21%
633.54K
12.71%
720.37K
13.70%
817.57K
13.49%
1.08M
32.33%
1.60M
47.81%
6.37M
298.32%
8.44M
32.48%
16.33M
93.50%
weighted average shs out dil
371.66K
-
505.43K
35.99%
562.09K
11.21%
633.54K
12.71%
720.37K
13.70%
817.57K
13.49%
1.08M
32.33%
1.60M
47.81%
6.37M
298.32%
8.44M
32.48%
16.33M
93.50%
eps
1
-
-1.17
217%
-4.54
288.03%
-6.67
46.92%
-5.32
20.24%
-5.20
2.26%
-7.09
36.35%
-5.58
21.30%
-2.25
59.68%
-1.81
19.56%
-1.23
32.04%
epsdiluted
1
-
-1.17
217%
-4.54
288.03%
-6.67
46.92%
-5.32
20.24%
-5.20
2.26%
-7.09
36.35%
-5.58
21.30%
-2.25
59.68%
-1.81
19.56%
-1.23
32.04%

All numbers in USD (except ratios and percentages)